- Category
- Micro (2024-25)
- Udyam number
- UDYAM-GJ-01-0013132

Gliesse Pharmaceuticals Private Limited
About Gliesse Pharmaceuticals Private Limited
Data last updated:
Gliesse Pharmaceuticals Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 August 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24110GJ2020PTC115404. Its GSTIN is 24AAICG4464D1ZS (Gujarat).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹10 Lakh. It is led by directors including Ruchi Darshan Shah and Jatinbhai Siddharthbhai Shah.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 10th Floor Shop No. 1007 Atlantis Prahlad Nagar Road Satellite, Ahmedabad, Gujarat, India – 380015.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.78 Cr, a growth of 22% compared to the previous year. For the same year it recorded a net profit of ₹1.38 Cr (net margin 20.3%) and EBITDA of ₹1.4 Cr (EBITDA margin 20.7%). Revenue has grown at a compounded annual rate (CAGR) of 665% over three years.
Gliesse Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0013132).
Company details
Recognitions & Rankings of Gliesse Pharmaceuticals
Contact details
Gliesse Pharmaceuticals Private Limited's registered office is in Ahmedabad, Gujarat. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Social Media
- Registered Address10th Floor Shop No. 1007 Atlantis Prahlad Nagar Road Satellite, Ahmedabad, Gujarat, India – 380015
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Gliesse Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Gliesse Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Gliesse Pharmaceuticals Private Limited, buy the company report.
Financials of Gliesse Pharmaceuticals Private Limited
FY 2024 filings availableGliesse Pharmaceuticals Private Limited reported revenue of ₹6.78 Cr (up 22% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 665% over three years, including 22% growth in the latest year. EBITDA rose 58% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.4 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.38 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 20.7% | ||||
| Net Profit Margin | 20.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Gliesse Pharmaceuticals Private Limited, buy the company report.
Board of directors of Gliesse Pharmaceuticals Private Limited
Gliesse Pharmaceuticals has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ruchi Darshan Shah Also directs: HNMS Ventures LLP | Director | 01 Jan 2024 | 2 Years 10 Months | Current |
| Jatinbhai Siddharthbhai Shah Also directs: Espee Lifesciences Private Limited, Rampex Labs Private Limited, Espee International Finechempharma Private Limited and 2 more | Director | 08 Aug 2020 | 6 Years 3 Months | Current |
| Mitaben Dineshbhai Vakil | Director | 01 Jan 2024 | 2 Years 10 Months | Current |
| Neel Hetal Shah | Director | 08 Aug 2020 | 6 Years 3 Months | Current |
Peer comparison
Gliesse Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Beid Healthcare Private Limited | ₹6.81 Cr (FY 2024) | -77.0% | Navi Mumbai, Maharashtra, India | |||
| Gliesse Pharmaceuticals Private Limitedthis company | ₹6.78 Cr (FY 2025) | ₹1.38 Cr | 20.3% | 22.0% | Ahmedabad, Gujarat, India | |
| Eshmun Biotech Private Limited | ₹6.77 Cr (FY 2025) | 68.0% | Bathinda, Punjab, India | |||
| Sanora Pharmaceuticals Private Limited | ₹6.77 Cr (FY 2025) | 39.0% | Mumbai, Maharashtra, India | |||
| Anant Pharmaceuticals Private Limited | ₹6.76 Cr (FY 2025) | 7.0% | Ambernath East, Maharashtra, India | |||
| Ambitree India Private Limited | ₹6.75 Cr (FY 2024) | -4.0% | Delhi, India |
To see the full peer comparison of Gliesse Pharmaceuticals Private Limited, buy the company report.
Auditor
Gliesse Pharmaceuticals Private Limited is audited by Nautam R Vakil & CO for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Nautam R Vakil & CO | FY 2024 | 102443 |
Shareholding
The shareholding of Gliesse Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Gliesse Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Gliesse Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Gliesse Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Gliesse Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAICG4464D1ZS | Gujarat | Active | 27 Aug 2020 |
To see the full GST registrations and return filing status of Gliesse Pharmaceuticals Private Limited, buy the company report.
Recent activity
Gliesse Pharmaceuticals Private Limited has 4 board changes on record since 2020: 4 appointments. The latest: Mitaben Dineshbhai Vakil was appointed as Director on 01 Jan 2024.
Frequently asked questions
Gliesse Pharmaceuticals is an active private limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 August 2020 (6+ years old) and is registered under CIN U24110GJ2020PTC115404.
Gliesse Pharmaceuticals has 4 current directors:
- Ruchi Darshan Shah - Director
- Jatinbhai Siddharthbhai Shah - Director
- Mitaben Dineshbhai Vakil - Director
- Neel Hetal Shah - Director
The latest financial statements of Gliesse Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Gliesse Pharmaceuticals is 24AAICG4464D1ZS, registered in Gujarat.
The CIN (Corporate Identification Number) of Gliesse Pharmaceuticals is U24110GJ2020PTC115404. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Gliesse Pharmaceuticals was incorporated on 08 August 2020, making it 6+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Gliesse Pharmaceuticals by revenue are Beid Healthcare Private Limited, Eshmun Biotech Private Limited, Sanora Pharmaceuticals Private Limited, Anant Pharmaceuticals Private Limited, Ambitree India Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Mitaben Dineshbhai Vakil was appointed as Director on 01 Jan 2024. Ruchi Darshan Shah was appointed as Director on 01 Jan 2024. Jatinbhai Siddharthbhai Shah was appointed as Director on 08 Aug 2020. Gliesse Pharmaceuticals has 4 board changes on record in total.
Yes, Gliesse Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-GJ-01-0013132).
The registered office of Gliesse Pharmaceuticals is at 10th Floor Shop No. 1007 Atlantis Prahlad Nagar Road Satellite, Ahmedabad, Gujarat, India – 380015.
Gliesse Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.

